Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page
- Check5 days agoChange DetectedDifference0.4%
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.4%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedSeveral key resources related to leukemia and treatment options have been removed, including links to MedlinePlus and various NIH disease pages, which may impact access to important medical information.SummaryDifference4%
- Check41 days agoChange DetectedNew resources related to leukemia and treatments, including links to MedlinePlus and NIH rare disease information, have been added, enhancing the site's informational offerings.SummaryDifference0.5%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.